Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127208011 | 12720801 | 1 | I | 20150326 | 20160830 | 20160907 | 20160907 | EXP | FR-JNJFOC-20160826021 | JANSSEN | 38.22 | YR | A | M | Y | 0.00000 | 20160907 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127208011 | 12720801 | 1 | SS | PREZISTA | DARUNAVIR ETHANOLATE | 1 | Oral | Y | N | 0 | 1 | DF | TABLETS | QD | |||||
| 127208011 | 12720801 | 2 | PS | PREZISTA | DARUNAVIR ETHANOLATE | 1 | Oral | Y | N | 21976 | 1 | DF | TABLETS | QD | |||||
| 127208011 | 12720801 | 3 | SS | PYRIMETHAMINE | PYRIMETHAMINE | 1 | Oral | Y | 0 | 50 | MG | TABLET | QD | ||||||
| 127208011 | 12720801 | 4 | SS | WELLVONE | ATOVAQUONE | 1 | Oral | Y | 0 | 750 | MG | UNSPECIFIED | BID | ||||||
| 127208011 | 12720801 | 5 | SS | COUMADINE | WARFARIN SODIUM | 1 | Oral | Y | 0 | 2 | MG | UNSPECIFIED | QD | ||||||
| 127208011 | 12720801 | 6 | SS | NORVIR | RITONAVIR | 1 | Oral | Y | 0 | 1 | DF | UNSPECIFIED | QD | ||||||
| 127208011 | 12720801 | 7 | SS | NORVIR | RITONAVIR | 1 | Oral | Y | 0 | 1 | DF | UNSPECIFIED | QD | ||||||
| 127208011 | 12720801 | 8 | C | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 0 | 1 | DF | FILM COATED TABLET | QD | |||||||
| 127208011 | 12720801 | 9 | C | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 0 | 1 | DF | FILM COATED TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127208011 | 12720801 | 1 | Acquired immunodeficiency syndrome |
| 127208011 | 12720801 | 2 | HIV infection |
| 127208011 | 12720801 | 3 | Toxoplasmosis prophylaxis |
| 127208011 | 12720801 | 4 | Toxoplasmosis prophylaxis |
| 127208011 | 12720801 | 5 | Phlebitis |
| 127208011 | 12720801 | 6 | Acquired immunodeficiency syndrome |
| 127208011 | 12720801 | 7 | HIV infection |
| 127208011 | 12720801 | 8 | Acquired immunodeficiency syndrome |
| 127208011 | 12720801 | 9 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127208011 | 12720801 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127208011 | 12720801 | Pancytopenia | |
| 127208011 | 12720801 | Treatment noncompliance |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127208011 | 12720801 | 1 | 20150326 | 20151215 | 0 | |
| 127208011 | 12720801 | 2 | 20150326 | 20151215 | 0 | |
| 127208011 | 12720801 | 3 | 20150609 | 20151215 | 0 | |
| 127208011 | 12720801 | 4 | 20150609 | 20151215 | 0 | |
| 127208011 | 12720801 | 5 | 20151203 | 201512 | 0 | |
| 127208011 | 12720801 | 6 | 20150326 | 20151215 | 0 | |
| 127208011 | 12720801 | 7 | 20150326 | 20151215 | 0 | |
| 127208011 | 12720801 | 8 | 20150326 | 20151215 | 0 | |
| 127208011 | 12720801 | 9 | 20150326 | 20151215 | 0 |